Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

JOURNAL ARTICLE

REVIEW

Arginine vasopressin vs. terlipressin in the treatment of shock states

Mervyn Singer

Best Practice & Research. Clinical Anaesthesiology 2008, 22 (2): 359-68

The synthetic vasopressin analogue, terlipressin, is being increasingly used to treat catecholamine-resistant hypotension in septic shock and other conditions. While terlipressin holds some theoretical and anecdotal advantages over vasopressin, this has not been formally tested in prospective randomised trials. This review analyses the published literature and makes comparisons, where possible, between vasopressin and terlipressin.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Vasopressin in sepsis and septic shock. T G Kampmeier, S Rehberg, M Westphal, M Lange Minerva Anestesiologica 2010, 76 (10): 844-50

Comment: Terlipressin for children with extremely low cardiac output after open heart surgery. Sascha Meyer Annals of Pharmacotherapy 2009, 43 (7): 1375-6; author reply 1376

Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis. Matthias Lange, Christian Ertmer, Martin Westphal Intensive Care Medicine 2008, 34 (5): 821-32

Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock. Sebastian Rehberg, Christian Ertmer, Gabriele Köhler, Hans-Ulrich Spiegel, Andrea Morelli, Matthias Lange, Katharina Moll, Katrin Schlack, Hugo Van Aken, Fuhong Su, Jean-Louis Vincent, Martin Westphal Intensive Care Medicine 2009, 35 (7): 1286-96

Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock. Andrea Morelli, Christian Ertmer, Paolo Pietropaoli, Martin Westphal Expert Opinion on Pharmacotherapy 2009, 10 (15): 2569-75

Clinical review: Vasopressin and terlipressin in septic shock patients. Anne Delmas, Marc Leone, Sébastien Rousseau, Jacques Albanèse, Claude Martin Critical Care: the Official Journal of the Critical Care Forum 2005, 9 (2): 212-22

Vasopressin analogues and V1a receptor agonists in septic shock. Marc O Maybauer, Dirk M Maybauer Inflammation Research: Official Journal of the European Histamine Research Society ... [et Al.] 2011, 60 (5): 425-7

Vasopressin and terlipressin in neonates and children with refractory septic shock. Paolo Biban, Marcella Gaffuri Current Drug Metabolism 2013, 14 (2): 186-92

Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Andrea Morelli, Christian Ertmer, Sebastian Rehberg, Matthias Lange, Alessandra Orecchioni, Valeria Cecchini, Alessandra Bachetoni, Mariadomenica D'Alessandro, Hugo Van Aken, Paolo Pietropaoli, Martin Westphal Critical Care: the Official Journal of the Critical Care Forum 2009, 13 (4): R130

[Vasopressin and its analogues in the therapy of shock]. F Novák, H Lubanda, R Onderková, A Zák Casopís Lékar̆ů C̆eských 2004, 143 (5): 307-8, 310-2

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Arginine vasopressin vs. terlipressin in the treatment of shock states

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips